Dr. Wiedmeier is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
13400 E Shea Blvd
Scottsdale, AZ 85259Phone+1 480-301-8000
Summary
- Dr. Julia Wiedmeier-Nutor is an oncologist in Scottsdale, AZ and is affiliated with Mayo Clinic Hospital. She received her medical degree from Oregon Health and Science University School of Medicine. She specializes in cancer genetics/cancer risk assessment and hematologic oncology.
Education & Training
- Mayo Clinic College of Medicine and Science (Phoenix)Fellowship, Hematology and Medical Oncology, 2020 - 2023
- Mayo Clinic College of Medicine and Science (Scottsdale)Residency, Internal Medicine, 2017 - 2020
- Oregon Health and Science University School of MedicineClass of 2017, MD
- Howard Hughes Medical Institute (HHMI)Fellowship, Cancer , HHMI Fellow, 2015 - 2016
- UNIVERSITY OF UTAH SCHOOL OF MEDICINEMPH
Certifications & Licensure
- AZ State Medical License 2018 - 2025
- MN State Medical License 2022 - 2022
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- DAVID R SANDERSON ACADEMIC ACHIEVEMENT AWARD MAYO CLINIC AZ, 2020
- SPIRIT OF MAYO 2020 NOMINEE MAYO CLINIC AZ, 2020
- ACP Resident/Fellow of the Year American College of Physicians AZ, 2019
- Join now to see all
Publications & Presentations
PubMed
- 8 citationsDifferential prognosis of single and multiple TP53 abnormalities in high-count MBL and untreated CLL.Rosalie Griffin, Julia E Wiedmeier-Nutor, Sameer A Parikh, Chantal E McCabe, Daniel R O'Brien
Blood Advances. 2023-07-11 - 8 citationsResponse to COVID-19 Vaccination Post-CAR T Therapy in Patients With Non-Hodgkin Lymphoma and Multiple Myeloma.Julia E Wiedmeier-Nutor, Madiha Iqbal, Allison C Rosenthal, Evandro D Bezerra, Juan Esteban Garcia-Robledo
Clinical Lymphoma, Myeloma & Leukemia. 2023-06-01 - Correction: Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients.Rodrigo Fonseca, Mariano Arribas, Julia E Wiedmeier-Nutor, Yael N Kusne, Miguel González Vélez
Blood Cancer Journal. 2023-05-26
Abstracts/Posters
- 2574 Clonal Hematopoiesis in Older Women with Extremely Skewed, Non-Random X-Inactivation Is Associated with Previous Cardiovascular and Cerebrovascular EventsEmily Marre, MPH1*, Julia Erin Wiedmeier, MD, MPH2*, Zhenzhen Zhang, PhD3*, Hyunjung Lee4*, Dana Parker5*, Kelsey Westerlund1*, Christopher A. Eide6*, Catherine Kato1*..., ASH-American Society of Hematology
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: